acquisition

Showing 15 posts of 125 posts found.

Brenntag acquires mcePharma to expand GMP capabilities in biopharma services

June 5, 2025
Manufacturing and Production, Mergers and Acquisitions Brenntag Specialities, Corporate, acquisition, continuous monitoring platform (CMP), mcePharma

Brenntag Specialties has acquired Czech-based mcePharma, strengthening its position in the pharma and biopharma industries through expanded continuous monitoring platform …

handshake_2

Curium Pharma announces acquisition of Monrol

April 3, 2025
Manufacturing and Production, Research and Development Curium Pharma, Monrol, Oncology, acquisition, nuclear medicine, radiopharmaceutical products

Curium Pharma, a nuclear medicine company, has acquired Eczacıbaşı-Monrol Nuclear Products (Monrol), a nuclear medicine player. With facilities across Europe …

Enosium Life Science acquires RWEality

April 3, 2025
Business Services, Consultancy Consultancy, Corporate, Enosium Life Sciences, RWEality, acquisition, life sciences, research and development

Enosium Life Science, which specialises in life sciences, has acquired RWEality, a consultancy focused on public policies, technology and healthcare …

CANDOR Bioscience acquired by Medix Biochemica

January 31, 2025
Sales and Marketing CANDOR biosciences, Diagnostics, Medix biochemica, acquisition, in vitro diagnostics

CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in …

Agilent to acquire BIOVECTRA for $925m

July 24, 2024
Business Services Agilent, CMDO, Pharmacy, acquisition

Agilent Technologies has announced that it has signed a definitive agreement to acquire BIOVECTRA, a leading specialised contract development and …

Pharmaxo acquired by Icon Group in strategic partnership

July 10, 2024
Business Services Oncology, Pharmaxo, acquisition, strategic parnership

Pharmaxo has announced that it is joining Icon Group as part of a strategic partnership intended to establish a global …

Certara to acquire Chemaxon for drug discovery portfolio

July 10, 2024
Business Services Certara, Chemaxon, Pharmacy, acquisition, drug discovery

Certara and Chemaxon have announced that they have signed a definitive agreement under which Certara will acquire Chemaxon. The deal …

Merck to acquire EyeBio for an upfront $1.3bn

May 31, 2024
Business Services EyeBio, Merck, Opthalmology, acquisition, ophthalmology

Merck, known as MSD outside of the US and Canada, and EyeBiotech Limited, have announced that the two companies have …

BioGen to acquire Human Immunology Biosciences for $1.15bn

May 23, 2024
Business Services Biogen, HI-Bio, Immunology, acquisition, immunology

BioGen and Human Immunology Biosciences (HI-Bio) have announced that they have entered into a definitive agreement for Biogen to acquire …

Merck to acquire Mirus Bio for $600m

May 23, 2024
Business Services Merck, Pharmacy, acquisition, gene therapies

Merck has announced that it has signed a definitive agreement to acquire Mirus Bio for $600m.

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024
Manufacturing and Production Eli Lilly, Nexus Pharmaceuticals, Pharmacy, acquisition, facility

Eli Lilly and Nexus Pharmaceuticals have announced that they have entered into a definitive agreement for Eli Lilly to acquire …

Vertex to acquire Alpine Immune Sciences for $4.9bn

April 11, 2024
Business Services Alpine Immune Sciences, Nephrology, Vertex pharmaceuticals, acquisition, nephropathy

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will …

Johnson & Johnson to acquire Shockwave Medical

April 8, 2024
Business Services Cardiology, Johnson & Johnson, Shockwave Medical, acquisition

Johnson & Johnson (J&J) and Shockwave Medical have announced that they have entered into a definitive agreement under which J&J …

AbbVie to acquire Landos Biopharma for approximately $137.5m

March 26, 2024
Business Services AbbVie, Landos Biopharma, Pharmacy, acquisition

AbbVie and Landos Biopharma have announced that they have entered into a definitive agreement under which AbbVie will acquire Landos …

AstraZeneca to acquire Fusion for approximately $2bn

March 19, 2024
Business Services AstraZeneca, Fusion Pharmaceuticals, Oncology, acquisition, radioconjugates

AstraZeneca has announced that it has entered into a definitive agreement to acquire Fusion Pharmaceuticals for an approximate $2bn. This …

The Gateway to Local Adoption Series

Latest content